| CAS NO: | 5959-95-5 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 500mg | 电议 |
| 1g | 电议 |
| 2g | 电议 |
| 5g | 电议 |
| 10g | 电议 |
| 50g | 电议 |
| Molecular Weight (MW) | 146.14 |
|---|---|
| Formula | C5H10N2O3 |
| CAS No. | 5959-95-5 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility(In vitro) | DMSO: <1 mg/mL |
| Water: 9 mg/mL (61.58 mM) | |
| Ethanol: <1 mg/mL | |
| SMILES | N[C@H](CCC(N)=O)C(O)=O |
| Synonyms | H-D-Gln-OH |
| In Vitro | In vitroactivity: In catabolic states of injury and illness, glutamine becomes conditionally-essential (requiring intake from food or supplements). Glutamine is the most abundant naturally occurring, non-essential amino acid in the human body and one of the few amino acids that can directly cross the blood–brain barrier. Glutamine is a key pharmaconutrient in the body's response to stress and injury. Glutamine exerts its protective effects via multiple mechanisms, including direct protection of cells and tissue from injury, attenuation inflammation, and preservation of metabolic function. |
|---|---|
| In Vivo | Glutamine shows the greatest benefit when administered at doses greater than 0.35 g/kg/day, with optimal benefit potentially occurring at 0.5 g/kg/day. |
| Animal model | |
| Formulation & Dosage | |
| References | Am J Physiol. 1998 Apr;274(4 Pt 1):C1101-7; World Rev Nutr Diet. 2013;105:90-6. |
m.cnreagent.com
